Literature DB >> 21674222

Cancer-associated retinopathy presenting as retinal vasculitis with a negative ERG suggestive of on-bipolar cell pathway dysfunction.

Anastasios Anastasakis1, Andrew D Dick, Erika M Damato, Paul G Spry, Mohamed A Majid.   

Abstract

A 62-year-old female patient presented to our clinic complaining of a 2 month history of shimmering photopsias and floaters. An ocular examination, fluorescein angiography, and electrophysiological testing were obtained that suggested either an inflammatory retinal vasculitis or a paraneoplastic syndrome. Melanoma-associated retinopathy was highly suspected despite the absence of previous history for cutaneous melanoma since an electronegative scotopic ERG was recorded on standard flash electroretinography. Additional investigations revealed the presence of a primary breast tumor with secondary lung and pancreatic metastasis that led to the diagnosis of cancer-associated retinopathy. The patient received chemotherapy and 4 months after the initial presentation her visual complaints but also her retinal function showed marked improvement. Cancer-associated retinopathy needs to be considered in patients presenting with retinal vasculitis and electrophysiological testing can tailor the approach in these cases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21674222     DOI: 10.1007/s10633-011-9277-y

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  13 in total

1.  Nature of the cone ON-pathway dysfunction in melanoma-associated retinopathy.

Authors:  Kenneth R Alexander; Claire S Barnes; Gerald A Fishman; Ann H Milam
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-04       Impact factor: 4.799

Review 2.  Cancer-associated retinopathy: a new mechanistic insight on vascular remodeling.

Authors:  Renhai Cao; Yihai Cao
Journal:  Cell Cycle       Date:  2010-05-15       Impact factor: 4.534

Review 3.  The negative ERG: clinical phenotypes and disease mechanisms of inner retinal dysfunction.

Authors:  Isabelle Audo; Anthony G Robson; Graham E Holder; Anthony T Moore
Journal:  Surv Ophthalmol       Date:  2008 Jan-Feb       Impact factor: 6.048

Review 4.  Cancer associated retinopathy (CAR): An autoimmune-mediated paraneoplastic syndrome.

Authors:  Nadia Khan; John J Huang; C Stephen Foster
Journal:  Semin Ophthalmol       Date:  2006 Jul-Sep       Impact factor: 1.975

5.  The incidence of negative ERG in clinical practice.

Authors:  A H Koh; C R Hogg; G E Holder
Journal:  Doc Ophthalmol       Date:  2001-01       Impact factor: 2.379

6.  Blindness caused by photoreceptor degeneration as a remote effect of cancer.

Authors:  R A Sawyer; J B Selhorst; L E Zimmerman; W F Hoyt
Journal:  Am J Ophthalmol       Date:  1976-05       Impact factor: 5.258

Review 7.  Non-cancerous ophthalmic clues to non-ocular cancer.

Authors:  Dennis M Robertson
Journal:  Surv Ophthalmol       Date:  2002 Sep-Oct       Impact factor: 6.048

8.  Mechanisms of photoreceptor cell death in cancer-associated retinopathy.

Authors:  T Maeda; A Maeda; I Maruyama; K I Ogawa ; Y Kuroki; H Sahara; N Sato; H Ohguro
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-03       Impact factor: 4.799

9.  Cancer-associated retinopathy with retinal periphlebitis in a patient with ovarian cancer.

Authors:  Stephen J Kim; Hassanain S Toma; Charles E Thirkill; James P Dunn
Journal:  Ocul Immunol Inflamm       Date:  2010-04       Impact factor: 3.070

Review 10.  Selective immunohistochemical staining in the paraneoplastic retinopathy syndrome.

Authors:  J F Rizzo; J W Gittinger
Journal:  Ophthalmology       Date:  1992-08       Impact factor: 12.079

View more
  12 in total

1.  Case of paraneoplastic retinopathy with retinal ON-bipolar cell dysfunction and subsequent resolution of ERGs.

Authors:  Shinji Ueno; Ayami Nakanishi; Kayo Nishi; Shiro Suzuki; Hiroko Terasaki
Journal:  Doc Ophthalmol       Date:  2014-11-13       Impact factor: 2.379

2.  Vasculitis associated with immune checkpoint inhibitors-a systematic review.

Authors:  Anisha Daxini; Keri Cronin; Antoine G Sreih
Journal:  Clin Rheumatol       Date:  2018-06-19       Impact factor: 2.980

3.  Cancer-associated Retinopathy Developing After 10 Years of Complete Breast Cancer Remission.

Authors:  Nozomi Igarashi; Hiromasa Sawamura; Toshikatsu Kaburaki; Makoto Aihara
Journal:  Neuroophthalmology       Date:  2018-05-23

4.  Cancer-associated retinopathy after surgery for breast cancer: a case report and review of the literature.

Authors:  Mirei Kamei; Yutaka Fujitomi; Yoshiyuki Kondo; Toru Adachi; Kohei Shibata; Yohei Takumi; Miyuki Abe; Kenji Sugio
Journal:  Surg Case Rep       Date:  2018-01-23

5.  Efficacy of rituximab in non-paraneoplastic autoimmune retinopathy.

Authors:  Katherine Boudreault; Sally Justus; Jesse D Sengillo; Kaspar Schuerch; Winston Lee; Thiago Cabral; Stephen H Tsang
Journal:  Orphanet J Rare Dis       Date:  2017-07-15       Impact factor: 4.123

6.  Acute progressive paravascular placoid neuroretinopathy with negative-type electroretinography in paraneoplastic retinopathy.

Authors:  Fred K Chen; Avenell L Chew; Dan Zhang; Shang-Chih Chen; Enid Chelva; Erandi Chandrasekera; Eleanor M H Koay; John Forrester; Samuel McLenachan
Journal:  Doc Ophthalmol       Date:  2017-04-05       Impact factor: 2.379

7.  Cancer-associated retinopathy preceding the diagnosis of cancer.

Authors:  Florence Hoogewoud; Pauline Butori; Philippe Blanche; Antoine P Brézin
Journal:  BMC Ophthalmol       Date:  2018-11-03       Impact factor: 2.209

8.  Identification and characterization of novel TRPM1 autoantibodies from serum of patients with melanoma-associated retinopathy.

Authors:  Juliette Varin; Margaret M Reynolds; Nassima Bouzidi; Sarah Tick; Juliette Wohlschlegel; Ondine Becquart; Christelle Michiels; Olivier Dereure; Robert M Duvoisin; Catherine W Morgans; José-Alain Sahel; Quentin Samaran; Bernard Guillot; José S Pulido; Isabelle Audo; Christina Zeitz
Journal:  PLoS One       Date:  2020-04-23       Impact factor: 3.240

9.  Presumed cancer-associated retinopathy (CAR) mimicking Sudden Acquired Retinal Degeneration Syndrome (SARDS) in canines.

Authors:  Sinisa D Grozdanic; Tatjana Lazic; Helga Kecova; Kabhilan Mohan; Grazyna Adamus; Markus H Kuehn
Journal:  Vet Ophthalmol       Date:  2020-12-27       Impact factor: 1.644

10.  Choroidal atrophy in a patient with paraneoplastic retinopathy and anti-TRPM1 antibody.

Authors:  Shinji Ueno; Yasuki Ito; Ruka Maruko; Mineo Kondo; Hiroko Terasaki
Journal:  Clin Ophthalmol       Date:  2014-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.